Avantor (NYSE:AVTR) Director Sanjeev Mehra Buys 125,000 Shares

Avantor, Inc. (NYSE:AVTR) Director Sanjeev Mehra acquired 125,000 shares of the firm’s stock in a transaction on Tuesday, March 10th. The stock was purchased at an average price of $8.01 per share, for a total transaction of $1,001,250.00. Following the transaction, the director directly owned 475,000 shares of the company’s stock, valued at approximately $3,804,750. This trade represents a 35.71% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Avantor Trading Up 1.3%

Shares of NYSE:AVTR traded up $0.11 during midday trading on Thursday, hitting $8.40. 462,985 shares of the stock traded hands, compared to its average volume of 12,264,904. The company has a quick ratio of 1.18, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. The business’s 50 day moving average is $10.51 and its two-hundred day moving average is $11.75. The stock has a market capitalization of $5.73 billion, a PE ratio of -10.72, a P/E/G ratio of 3.20 and a beta of 0.97. Avantor, Inc. has a one year low of $7.82 and a one year high of $17.11.

Avantor (NYSE:AVTR) last posted its earnings results on Wednesday, February 11th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.01. The company had revenue of $1.66 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Avantor had a positive return on equity of 10.45% and a negative net margin of 8.09%.Avantor’s quarterly revenue was down 1.4% on a year-over-year basis. During the same period last year, the firm earned $0.27 earnings per share. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. As a group, research analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current year.

Hedge Funds Weigh In On Avantor

Institutional investors and hedge funds have recently made changes to their positions in the business. TD Private Client Wealth LLC boosted its position in shares of Avantor by 9.2% in the 3rd quarter. TD Private Client Wealth LLC now owns 7,985 shares of the company’s stock worth $100,000 after purchasing an additional 670 shares in the last quarter. Private Trust Co. NA raised its stake in Avantor by 46.2% during the fourth quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock valued at $32,000 after buying an additional 875 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Avantor by 28.1% in the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock worth $49,000 after acquiring an additional 905 shares in the last quarter. TD Waterhouse Canada Inc. boosted its holdings in Avantor by 2.5% in the third quarter. TD Waterhouse Canada Inc. now owns 38,977 shares of the company’s stock worth $532,000 after acquiring an additional 966 shares in the last quarter. Finally, SG Americas Securities LLC grew its stake in shares of Avantor by 2.7% in the second quarter. SG Americas Securities LLC now owns 37,078 shares of the company’s stock worth $499,000 after acquiring an additional 979 shares during the last quarter. Institutional investors own 95.08% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently commented on AVTR shares. Zacks Research downgraded Avantor from a “hold” rating to a “strong sell” rating in a report on Friday, February 13th. Robert W. Baird set a $11.00 price target on shares of Avantor in a report on Thursday, February 12th. Jefferies Financial Group reissued an “underperform” rating and set a $8.00 price objective on shares of Avantor in a research report on Thursday, February 12th. Stifel Nicolaus set a $10.00 price objective on shares of Avantor in a report on Thursday, February 12th. Finally, Evercore set a $10.00 target price on shares of Avantor in a research report on Wednesday, February 11th. Three research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $11.80.

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.